Gene Express

Gene Express, Inc. is a molecular diagnostics and pharmacogenomics company that specializes in the standardization of gene expression measurement. The company's proprietary platform, Standardized Reverse Transcription Polymerase Chain Reaction (StaRT-PCR), provides a highly accurate and reproducible method for quantifying mRNA levels, addressing a critical need for consistency in clinical diagnostics and pharmaceutical research. Gene Express focuses on developing diagnostic and prognostic tests for oncology and respiratory diseases, with its lead product, LungExpress, aimed at improving lung cancer detection and patient stratification. Additionally, the company's technology is utilized in drug discovery and development to identify biomarkers, assess therapeutic efficacy, and support personalized medicine initiatives.